Browse by Audience
Skip to content
Papers of the Week
Spinal Cord Stimulation Explantation and Chronic Pain: A Systematic Review and Technology Recommendations.
Authors
Wahezi SE, Yener U, Naeimi T, Lewis JB, Yerra S, Sgobba P, Ciftci HB, Vydyanathan A, Chiu E, Cherkalin D, Darji JY, Masterson R, Lee D, Jarusriwanna A, Palee S, Ortiz NR, Caparo M, Dayon E, Fontaine C, Bikson M, Schatman ME, Pritzlaff SG, Deer TR, Hunter CWAbstract
Chronic pain affects 20.5% of the US population, costing $296 billion annually in lost productivity. Spinal cord stimulation (SCS) has become a key treatment for refractory neuropathic and nociceptive pain, with increasing usage due to technological advancements. However, the durability of SCS therapy, including explantation rates, remains a concern. Understanding explantation causes is essential for improving patient selection and device effectiveness. This study aims to analyze SCS explantation rates and reasons, as well as evaluate the financial burden of these procedures on the healthcare system.